| Active ingredient (INN) | Cefadroxil |
|---|---|
| Brand names | Teva-Cefadroxil |
| ATC level 5 | J01DB05 |
| ATC level 4 |
|---|
| J01DB |
| Therapeutic category | Auto-created by Health Canada — Drug Shortages Database scraper |
|---|
| Controlled substance | No |
|---|
| Marketing-authorisation holders | SANDOZ LIMITED, TEVA PHARMACEUTICALS USA, INC., NORTHSTAR RX LLC |
|---|
| Registrations on file | 5 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| CEFADROXIL 500MG CAPSULES | 500MG | capsule | 🇬🇧 GB | SANDOZ LIMITED | Active |
| Cefadroxil | 500mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Cefadroxil | 1000mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Cefadroxil | 250mg/5mL | suspension | 🇺🇸 US | NORTHSTAR RX LLC | Active |
| Cefadroxil | 500mg/5mL | suspension | 🇺🇸 US | NORTHSTAR RX LLC | Active |